3RTA - 30mg

Retatrutide is an investigational triple-receptor agonist targeting GLP-1, GIP, and glucagon receptors. Research has shown interest in its potential to influence multiple pathways involved in appetite regulation, energy expenditure, glucose metabolism, and body-weight reduction.

Studies have particularly examined retatrutide's potential for reducing food intake and body weight, while the glucagon component may contribute to increased energy expenditure and metabolic activity. This multi-pathway mechanism makes retatrutide an important subject of ongoing research into next-generation approaches to obesity and metabolic health. resilience